Dna encoding the chimpanzee prostaglandin e2 receptor ep4 subtype
CA 2403058 A1 · Owner: Pfizer Products Inc. · Inventors: Castleberry, Tessa A.; Smock, Steven Lee; Lu, Bihong
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides isolated chimpanzee EP4 protein DNA molecules, encoding said protein, vectors and cells carrying said DNA molecules specific , binding, partners for the protein and methods of determining ligands for chimpanzee EP4.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 13, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 13, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 13, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.